Thiazole orange (TO), a fluorescent dye originally synthesized for reticulocyte analysis, is characterized by a large fluorescence enhancement and high quantum yield on binding t o nucleic acids, particularly RNA. In addition, the dye readily permeates live cell membranes. We applied TO staining, followed by fluorescence-activated flow cytometric analysis, t o platelets in whole blood samples from hematologically normal subjects and patients with various quantitative platelet disorders. The percentage of TOpositive platelets in 50 control subjects was 8.6 & 2.8% (mean f SD) ranging from 2.8% t o 15.8%. In 21 thrombocytopenic patients whose bone marrow contained normal t o increased numbers of megakaryocytes, the percentage of fluorescently labeled platelets was significantly elevated ( P < .OOOl) t o 26.9 & 10.9% (range, 13.3% t o 57.1%). In contrast, the proportion of positively stained platelets in 23 patients with thrombocytopenia due t o impaired platelet
D that may be associated etiologically, thrombocytopenia results from only three pathophysiologic mechanisms: deficient production, accelerated destruction, and abnormal pooling of platelets. Abnormal platelet pooling or sequestration is almost invariably due to hypersplenism and is only to be suspected in the presence of significant splenic enlargement. In contrast, it may be difficult to distinguish between hypoproliferative and hyperdestructive forms of thrombocytopenia. The initial investigations in the evaluation of thrombocytopenic disorders usually include examination of a peripheral-blood film and bone marrow, the latter qualitatively differentiating the decreased megakaryocytes of hypoplasia from the increased number of megakaryocytes found in most cases of accelerated platelet destruction. Platelet volume distribution analysis,',' quantitation of platelet surface-bound immunoglobulin G (IgG),3-6 and platelet survival can be useful diagnostic adjuncts. However, these procedures have significant drawbacks: bone marrow aspirations and biopsies cause discomfort to the patient and are liable to subjective interpretation; platelet life-span measurements are time-consuming and expose the patient to radiation; and assay techniques used to quantify platelet-bound IgG are relatively complicated and difficult to perform in a clinical routine laboratory. Thus, there is a need ster, Albert-Schweitzer-StraDe 33, 4400 Miinster, FRG.
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0 I990 by The American Society of Hematology. 0006-4971/90/7501-0016$3.00/0 production (various conditions with reduced marrow megakaryocytes) did not significantly differ from the controls, whereas the absolute counts of TO-positive platelets were significantly lowered ( P < .OM1 1. Differences in the distributions of the percentage values as well as of the absolute counts for TO-positive platelets between the two patient groups were again highly significant ( P < .OOOI). Both the sensitivity and the specificity of this method in distinguishing between these categories of thrombocytopenia were 295%. We conclude that flow cytometric analysis of platelets after staining with TO is a sensitive and specific test that rapidly provides information on the thrombopoietic activity in thrombocytopenic disorders. Our data further suggest that increased amounts of residual RNA characterize platelets released under conditions of "stress thrombopoiesis."
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for a rapid, noninvasive test that helps classify the mechanism of thrombocytopenia.
Reticulocyte quantitation provides a simple means for assessing erythropoietic activity of the bone marrow. Therefore, the reticulocyte count represents a valuable diagnostic aid in categorizing anemias, the pathophysiology of which in many respects resembles that of thrombocytopenic disorders. The fluorescent dye thiazole orange (TO) has favorable physical characteristics that make it suitable for reticulocyte analysis by fluorescence-activated flow cytometry: it has a large fluorescence enhancement and high quantum yield on binding to nucleic acids, and it permeates live cell membranes."
In analogy to reticulocyte analysis, we have applied T O staining evaluated by fluorescence-activated flow cytometry to human platelets. The results of our study indicate that this simple and rapid technique distinguishes between thrombocytopenia caused by impaired platelet production and that due to increased platelet destruction. Our results also suggest that "stress platelets" produced under conditions of accelerated platelet destruction, like reticulocytes, are characterized by increased amounts of residual RNA.
MATERIALS AND METHODS
TO was kindly provided by Becton Dickinson (Mountain View, CA). A stock solution of TO (1 mg/mL) was made in methanol. Unless otherwise specified, the stock solution was diluted 1:20,000 in phosphate-buffered saline (PBS) containing 2 mmol/L ethylenediamine tetraacetate (EDTA) and 0.02% sodium azide. For staining, 5 pL of freshly drawn whole blood anticoagulated with EDTA was added to 1 mL of the diluted dye solution and incubated at room temperature for 2.5 hours or for the time periods indicated. Five microliters of the whole blood sample was added to 1 mL of PBS containing 2 mmol/L EDTA and 0.02% sodium azide; this sample served as an unstained control.
Samples were analyzed in a FACStar flow cytometer (Becton Dickinson) equipped with an argon-ion laser. Laser emission was adjusted to deliver 200 mW at 488 nm for excitation. Fluorescence was detected through a 530/30 nm bandpass filter. The instrument was calibrated for fluorescence and light scatter daily using 2 pm Calibrite heads (Becton Dickinson).
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Samples were passed through the laser beam through a 70-pm nozzle at a flow rate between 500 and 1,000 blood cells per second. Logarithmic amplification was used for the fluorescence signals, and linear amplification for light scatter signals. Data were collected and analyzed on a Hewlett Packard computer equipped with a Consort 30 program (Becton Dickinson).
In the whole blood analysis, platelets were identified on the basis of their forward-versus side-light scatter profile, which separated them from erythrocytes and white blood cells and set a gate around the platelet population. Studies with platelet-rich plasma and washed erythrocytes confirmed that more than 95% of the cells appearing within the gated area were platelets and less than 5% of the platelet population appeared outside this gate. For each sample, a minimum of 5,000 cells within the platelet gate was analyzed for fluorescence emission. To exclude cell autofluorescence and instrument noise, a fluorescence histogram of an unstaind control sample was examined, and the position of the middle marker was chosen in a way that more than 99% of the platelet population was to the left of this marker. The two end markers were set at 0 and 255 channel numbers. The same gates and marker positions were retained during analysis of the stained sample. The highly fluorescent subset of the platelet population that appeared between the middle and right marker in the fluorescence histogram of the stained sample was considered to represent TO-positive platelets.
Platelet counts and volume measurements were performed on fresh whole blood samples collected in EDTA using an electronic particle counter (Series 810 Platelet Analyzer; Baker Instruments, Allentown, PA). Platelet counts of less than 30 x 109/L were confirmed by phase contrast microscopy.
The control group comprised 50 hematologically normal subjects, 25 men and 25 women, aged 21 to 90 years, with platelet counts in the range of 150 to 350 x 109/L. Patient group 1 consisted of 21 patients with thrombocytopenia and normal or increased numbers of megakaryocytes on qualitative evaluation of bone marrow aspirates. One patient had thrombotic thromhocytopenic purpura and the other 20 met the conventional criteria for the diagnosis of immune thrombocytopenia." Of this group, 14 were classified as idiopathic, 4 were secondary (1 case of non-Hodgkin's lymphoma and 3 cases of human immunodeficiency virus-related thrombocytopenia), and 2 were drug-induced.
Group 2 comprised 23 patients with thrombocytopenia in association with decreased or absent bone marrow megakaryocytes. In 13 patients megakaryocytic hypoplasia was confirmed by assessment of bone marrow samples available for review. These included 4 cases of acute leukemia, 2 cases of blast crisis in chronic myelogenous leukemia, 2 cases of myelodysplastic syndrome, 2 cases of aplastic anemia, and single cases of amyloidosis, hemochromatosis, and marrow infiltration by metastatic carcinoma. Ten additional patients were studied who developed thrombocytopenia after myelosuppressive drug treatment for acute leukemia. Specifically excluded from the study were thrombocytopenic patients who had undergone splenectomy, exhibited splenomegaly on physical examination, or received platelet transfusions within 48 hours before blood sampling.
Group 3 consisted of 13 patients with repeatedly elevated platelet counts of more than 400 x 109/L. Five patients had thrombocythemia caused by myeloproliferative disorders (three cases of chronic myelogenous leukemia and two cases of essential thrombocythemia). None of them received cytoreductive chemotherapy at the time of entry into the study. The underlying diseases in the remaining eight patients with reactive thrombocytosis were inflammatory disorders in four, carcinoma in two, and Hodgin's disease in two cases.
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platelets, expressed as either absolute counts or percentages of total platelet counts, was determined by the Wilcoxon-Mann-Whitney two-sample test. Correlation coefficients and the statistical significance of correlations between total platelet counts, mean platelet volumes (MPV), and percentages of TO-positive platelets were calculated using Spearman's method. Sensitivity and specificity were calculated as measurements of the diagnostic ability of the percentage of TO-positive platelets to discriminate thrombocytopenia with normal or increased numbers of bone marrow megakaryocytes from conditions with reduced megakaryocytes.
RESULTS
Using a fixed concentration of TO (50 ng/mL) in staining solutions, dye uptake by platelets in whole blood was found to depend significantly on the length of the time period chosen for incubation of the sample with the dye (Fig 1) . Up to an incubation time of 2.5 hours, the percentage of TO-positive platelets increased only slightly and, with few exceptions, remained in the range of below 10% in blood samples drawn from healthy individuals. Beyond 2.5 hours, further prolongation of the incubation time led to a shift in the fluorescence profile of the platelet population toward higher fluorescence intensities. This resulted in unacceptably high percentages of TO-positive platelets that increased linearly with the length of the incubation period, and reached almost 50% at 5 hours. The inset in Fig 1 demonstrates the concentration-response curve generated by analyzing the platelet population of whole blood samples after incubation with various dilutions of TO for 2.5 hours. For further analyses, we chose a constant incubation time of 2.5 hours using a concentration of 50 ng/mL of TO in staining solutions. samples of a healthy volunteer (A) and a patient with immune thrombocytopenic purpura (B). The position of the middle marker, which determined the percentage of the highly fluorescent platelets considered to represent the TOpositive subset, was adjusted during analysis of unstained control samples as described in the experimental section. Analysis of specimen B showed a bimodal distribution with a separate peak of exceedingly fluorescent platelets that constituted 26.6% of the total population. In contrast, platelets of the control subject appeared as a single, almost symmetrically distributed population, with only 9.8% of the platelets exhibiting a fluroescence intensity that distinctly exceeded cell autofluorescence and instrument background. Table 1 summarizes the results of TO analysis of platelets in whole blood samples from normal control subjects and various patient groups. In 50 hematologically normal volunteers, the mean number of platelets fluorescently labeled with TO amounted to 21.3 x IO9 7.9 x 109/L (mean + 1 SD), equivalent to 8.6% f 2.8% of the total platelet counts. There were no sex-or age-related differences in the normal range for TO-positive platelets (not shown). In patient group 1 with thrombocytopenia and normal or increased numbers of bone marrow megakaryocytes, the mean absolute count of p itively stained platelets was significantly lower (P < -005) than that seen in normal controls (Table 2) , despite substantial overlap in the distribution of the individual values measured in these two groups. However, absolute numbers of positive reacting platelets in patient group 1 were not reduced to the same extent as the total platelet counts. This resulted in percentage values for TO-stained platelets that were significantly (P < .0001) higher than in the normal donors. As a group, the patients with thrombocytopenia and reduced megakaryocytes had dramatically lower aboslute counts of positive reacting platelets than did either the control subjects (P < .0001) or patients of group 1 (P < .0001). However, in relation to total platelet counts, the percentage values of TO-positive platelets in patient group 2 remained in the range of the control subjects and, thus, were significantly lower (P < .0001) than in group 1 ( Table 2 ).
The number of fluorescently labeled platelets in patients with thrombocytosis was adequately raised, so that the percentage values were similar to those in the normal controls.
The percentage values for TO-positive platelets in the various study groups are compiled in Fig 3. Given a cutoff value of 14.2% (equivalent to the mean +2 SD of the values in the control group), 20 of 21 thrombocytopenic patients with normal or increased megakaryocytes had a n increased proportion of positively stained platelets (sensitivty 95%), whereas all 23 patients with decreased megakaryocytes had less than 14.2% of TO-positive platelets (specificity 100%).
No significant correlation was found between the percentage of TO-stained platelets and the platelet count, although an inverse association between these features cannot be excluded for thrombocytopenic patients with normal to increased numbers of megakaryocytes (r = -.42, P = .06).
Platelet volume distribution was analyzed in the control subjects (n = 50) and in a subgroup of 15 consecutive patients with different quantitative platelet disorders. MPV and the proportion of TO-positive platelets were not correlated in controls, whereas a significant association was established for the patient group studied (r = .60, P < -05).
Serial measurements were performed in single representative patients. Figure 4 shows the values obtained in two patients with immune thrombocytopenia. One patient r m vered spontaneously (A) while the other responded to corticosteroid treatment (B). In both cases, the increase in the platelet count was associated with a progressive reduction in the proportion of TO-positive platelets. Conversely, in patients recovering from thrombocytopenia with reduced numbers of marrow megakaryocytes, we occasionally observed a transient elevation in the percentage of positively stained platelets above the cutoff value of 14.2%.
DISCUSSION
Properties of TO as a fluorescent reticulocyte stain for use in flow cytometry were first investigated by Lee et al." They demonstrated that TO is excitable a t 488 nm, the optimal wavelength for argon-ion lasers, and that it is characterized by an approximately 3,000-fold fluorescence enhancement with a good quantum yield on binding to RNA. In addition, the dye readily permeates the membrane of viable blood 
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This report describes the first systematic study in which a reticulocyte staining technique, ie, TO staining, was applied to the analysis of platelets in whole blood in various quantitative platelet disorders. The results indicate that determination of the percentage of TO-positive platelets provides rapid and reliable information on the adequacy of thrombopoiesis Namal subjects vGroup 1 P c.005
Wihcm-Mann-Whitney two-sample test was used for significance testing. Group 1, patients with thrombocytopenia and normal or increased numbers of bone marrow megakawocytes; group 2, patients with thrombocytopenia and decreased megakaryocytes; group 3, patientswiththrombocytosis.
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in thrombocytopenic disorders. Thus, flow cytometric analysis of the platelet population after staining with TO should be clinically useful in identifying the prevailing mechanism of thrombocytopenia (eg, depressed platelet production or increased destruction), particularly in those clinical settings that require a rapid decision on therapeutic measures. Critical to this method is that an optimal concentration of the dye and an appropriate incubation period have to be chosen for the staining procedure. With the staining protocol used in our study, TO-positive platelets can be identified as a discrete, highly fluorescent subset (Fig 2) by setting the threshold separating fluorescence intensity with the aid of an unstained control sample. Under these conditions, the fluorescence signals exceeding by intensity cell autofluorescence and instrument noise are likely to reflect in platelets the presence of residual amounts of RNA. This assumption is supported by the observation that, in the virtual absence of RNA-containing reticulocytes, the fluorescence profile of a red blood cell population stained with TO does not differ from the profile of the unstained control," indicating that the fluorescence emission of intracellular dye depends on the binding to nucleic acids. Although platelets are derived from megakaryocytes as anucleate cells, they retain the ability to synthesize small amounts of suggesting that platelets contain vestigial amounts of RNA. Recently, platelet-specific RNA has been isolated from patients with myeloproliferative disorders" and, after enzymatic amplification, also from healthy individuals. 16 With the staining procedure used, binding to platelet nucleotides is unlikely to account for TO fluorescence. This is Samples of peripheral whole blood were stained by incubation with TO in PBS for 2.5 hours and analyzed by fluorescenceactivated flow cytometry as described in the Materials and Methods section. The patient groups are specified in more detail in Table 1. because platelets generally contain high levels of nucleotides," and a substantially greater proportion of fluorescently labeled platelets should then routinely be expected. However, we observed a dramatic shift in the fluorescence profile toward higher fluorescence intensities when the concentration of TO in staining solutions was raised or the time period for incubation of the sample with the dye was prolonged beyond 2.5 hours (Fig 1) . This shift might result from penetration of the dye into the dense granules where approximately two thirds of the platelet nucleotides are sequestered at enormous concentrations."
Patients with thrombocytopenia in association with normal to increased numbers of marrow megakaryocytes had significantly elevated percentages of platelets fluorescently labeled with TO, most likely due to increased amounts of residual RNA contained in their cytoplasm. As can be concluded from the bimodal distribution in the fluorescence histogram (Fig 2) , these platelets represent a distinct, presumably immature population. Studies in experimental thrombo~ytopenia'~,'~ and patients with immune thrombocytopenia' indicate that MPV increases under conditions of ''stress thrombopoiesis." In the patient group studied, we found a significant direct correlation between MPV and the percentage of TO-positive platelets. This finding supports the concept that TO-positive platelets constitute a less mature subset of platelets reflecting the thrombopoietic activity of a given population of megakaryocytes. Accordingly, serial measurements during recovery from hyperdestructive immune thrombocytopenia showed that the percentage of TO-positive platelets progressively returns to normal as the platelet count rises (Fig 4) . The observed variability in the proportion of TO-positive platelets could result from the heterogeneity of this patient group with respect to different phases of their disease. Alternatively, these variations might be explained by considerable differences in the individual thrombopoietic response to the reduced platelet count, as it has recently been described in patients with chronic autoimmune thrombocytopenic purpura.20
Patients with thrombocytopenia and reduced bone marrow megakaryocytes had strikingly lowered absolute counts of TO-positive platelets. However, the percentage values did not differ significantly from those of the control group. Similarly, patients with thrombocytosis had percentage values in the range of the controls, whereas the mean absolute number of TO-positive platelets was markedly higher than in the other groups studied. This indicates that the abolute number of TO-positive platelets should also be taken into consideration for a more accurate estimate of the thrombopoietic activity in these conditions. An alternative approach to assess the adequacy of thrombopoiesis might be the correction of the percentage value for the platelet count in a manner similar to the calculation of the reticulocyte index.
Overall, our data demonstrate that flow cytometric analysis of the platelet population in whole blood after staining with TO is a valuable diagnostic aid in the evaluation of thrombocytopenic disorders. The main advantages of this sensitive and specific method for clinical use reside in its simplicity and the rapid availability of results without causing discomfort to the patient. Furthermore, this technique should be useful in studying the pathophysiology of quantitative platelet disorders. 
